Skip to main content
. 2019 Sep 27;98(39):e17197. doi: 10.1097/MD.0000000000017197

Figure 1.

Figure 1

Nomogram predicting 1-, 2-, and 3-year cancer-specific survival (CSS) for patients with bone metastatic PCa.